Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Schmiedl

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|October 7, 2011
[Drug treatment of elderly patients]P A Thürmann, S Schmiedl
Der Urologe. Ausg. A|August 13, 2008
[Antibiotic prophylaxis for patients with transurethral resection of the prostate (TUR-P)]S Schmiedl, P A Thürmann, S Roth
Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress|February 5, 1999
[Information exchange via internet--possibilities, limits, future]S Schmiedl, M Geishauser, M Klöppel, et al.
Handchirurgie, Mikrochirurgie, Plastische Chirurgie : Organ Der Deutschsprachigen Arbeitsgemeinschaft Fur Handchirurgie : Organ Der Deutschsprachigen Arbeitsgemeinschaft Fur Mikrochirurgie Der Peripheren Nerven Und Gefasse : Organ Der V|August 10, 2000
[Color comparison of donor sites of free flaps and the face]M Geishauser, S Schmiedl, R Staudenmaier, et al.
European Journal of Clinical Pharmacology|June 18, 2021
A patient-centred web-based adverse drug reaction reporting system identifies not yet labelled potential safety issuesJ Hasford, F Bruchmann, M Lutz, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 21, 2009
Different time courses of nephrogenic systemic fibrosis: Is there a role for pharmacokinetic aspects in explaining a new clinical entity?S Schmiedl, U Wesselmann, P Lehmann, et al.
Clinical Pharmacology and Therapeutics|December 26, 2008
Declining public health burden of digoxin toxicity: decreased use or safer prescribing?S Schmiedl, M Rottenkolber, J Szymanski, et al.
Expert Opinion on Drug Safety|December 21, 2017
Preventable ADRs leading to hospitalization - results of a long-term prospective safety study with 6,427 ADR cases focusing on elderly patientsS Schmiedl, M Rottenkolber, J Szymanski, et al.
European Journal of Clinical Pharmacology|May 25, 2016
A methodological comparison of two European primary care databases and replication in a US claims database: inhaled long-acting beta-2-agonists and the risk of acute myocardial infarctionA Afonso, S Schmiedl, C Becker, et al.
Respiratory Medicine|May 16, 2015
Seasonal changes in prescribing of long-acting beta-2-agonists-containing drugsM Rottenkolber, E Voogd, L van Dijk, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|October 7, 2011
[Drug treatment of elderly patients]P A Thürmann, S Schmiedl
Der Urologe. Ausg. A|August 13, 2008
[Antibiotic prophylaxis for patients with transurethral resection of the prostate (TUR-P)]S Schmiedl, P A Thürmann, S Roth
Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress|February 5, 1999
[Information exchange via internet--possibilities, limits, future]S Schmiedl, M Geishauser, M Klöppel, et al.
Handchirurgie, Mikrochirurgie, Plastische Chirurgie : Organ Der Deutschsprachigen Arbeitsgemeinschaft Fur Handchirurgie : Organ Der Deutschsprachigen Arbeitsgemeinschaft Fur Mikrochirurgie Der Peripheren Nerven Und Gefasse : Organ Der V|August 10, 2000
[Color comparison of donor sites of free flaps and the face]M Geishauser, S Schmiedl, R Staudenmaier, et al.
European Journal of Clinical Pharmacology|June 18, 2021
A patient-centred web-based adverse drug reaction reporting system identifies not yet labelled potential safety issuesJ Hasford, F Bruchmann, M Lutz, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 21, 2009
Different time courses of nephrogenic systemic fibrosis: Is there a role for pharmacokinetic aspects in explaining a new clinical entity?S Schmiedl, U Wesselmann, P Lehmann, et al.
Clinical Pharmacology and Therapeutics|December 26, 2008
Declining public health burden of digoxin toxicity: decreased use or safer prescribing?S Schmiedl, M Rottenkolber, J Szymanski, et al.
Expert Opinion on Drug Safety|December 21, 2017
Preventable ADRs leading to hospitalization - results of a long-term prospective safety study with 6,427 ADR cases focusing on elderly patientsS Schmiedl, M Rottenkolber, J Szymanski, et al.
European Journal of Clinical Pharmacology|May 25, 2016
A methodological comparison of two European primary care databases and replication in a US claims database: inhaled long-acting beta-2-agonists and the risk of acute myocardial infarctionA Afonso, S Schmiedl, C Becker, et al.
Respiratory Medicine|May 16, 2015
Seasonal changes in prescribing of long-acting beta-2-agonists-containing drugsM Rottenkolber, E Voogd, L van Dijk, et al.
Pageof 2